NCT01088763 2014-11-05Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell LeukemiaNational Cancer Institute (NCI)Phase 1 Terminated129 enrolled